Compare Citius Pharmaceuticals Inc (CTXR) vs Jabil Inc (JBL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Jabil Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Jabil Inc trades at $362.4 (market cap $37.37B). The key difference: Jabil Inc is far larger — about 1867.6× Citius Pharmaceuticals Inc's market cap, and Jabil Inc pays a 0.09% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | JBL | |
|---|---|---|
Market Cap | $20.01M | $37.37B |
Sector | Health | Technology |
52-Week High | $1.82 | $385.50 |
52-Week Low | $0.48 | $192.49 |
Enterprise Value | $16.23M | $39.90B |
Dividend Yield | — | 0.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Jabil Inc
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →
